Castrate-resistant Prostate Cancer (CRPC)
1 competing product in clinical development for Castrate-resistant Prostate Cancer (CRPC).
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| eFT508 | eFFECTOR Therapeutics | Phase 2 | Terminated | 44 |